257 related articles for article (PubMed ID: 38157945)
1. The MR1/MAIT cell axis in CNS diseases.
Shrinivasan R; Wyatt-Johnson SK; Brutkiewicz RR
Brain Behav Immun; 2024 Feb; 116():321-328. PubMed ID: 38157945
[TBL] [Abstract][Full Text] [Related]
2. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
3. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
Corbett AJ; Awad W; Wang H; Chen Z
Front Immunol; 2020; 11():1961. PubMed ID: 32973800
[TBL] [Abstract][Full Text] [Related]
4. Control of the temporal development of Alzheimer's disease pathology by the MR1/MAIT cell axis.
Wyatt-Johnson SK; Kersey HN; Codocedo JF; Newell KL; Landreth GE; Lamb BT; Oblak AL; Brutkiewicz RR
J Neuroinflammation; 2023 Mar; 20(1):78. PubMed ID: 36944969
[TBL] [Abstract][Full Text] [Related]
5. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
[TBL] [Abstract][Full Text] [Related]
6. MAIT cells and MR1-antigen recognition.
Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
[TBL] [Abstract][Full Text] [Related]
7. Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil.
Ciacchi L; Mak JYW; Le JP; Fairlie DP; McCluskey J; Corbett AJ; Rossjohn J; Awad W
J Biol Chem; 2024 May; 300(5):107229. PubMed ID: 38537698
[TBL] [Abstract][Full Text] [Related]
8. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
9. TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.
Ussher JE; van Wilgenburg B; Hannaway RF; Ruustal K; Phalora P; Kurioka A; Hansen TH; Willberg CB; Phillips RE; Klenerman P
Eur J Immunol; 2016 Jul; 46(7):1600-14. PubMed ID: 27105778
[TBL] [Abstract][Full Text] [Related]
10. Viral Impacts on MR1 Antigen Presentation to MAIT Cells.
Samer C; Traves R; Purohit SK; Abendroth A; McWilliam HEG; Slobedman B
Crit Rev Immunol; 2021; 41(5):49-67. PubMed ID: 35381139
[TBL] [Abstract][Full Text] [Related]
11. Brain astrocytes and microglia express functional MR1 molecules that present microbial antigens to mucosal-associated invariant T (MAIT) cells.
Priya R; Brutkiewicz RR
J Neuroimmunol; 2020 Dec; 349():577428. PubMed ID: 33096293
[TBL] [Abstract][Full Text] [Related]
12. Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation.
Tastan C; Karhan E; Zhou W; Fleming E; Voigt AY; Yao X; Wang L; Horne M; Placek L; Kozhaya L; Oh J; Unutmaz D
Mucosal Immunol; 2018 Nov; 11(6):1591-1605. PubMed ID: 30115998
[TBL] [Abstract][Full Text] [Related]
13. Detection, Expansion, and Isolation of Human MAIT Cells.
Liu Y; Wang W; Wu X; Weng X
Methods Mol Biol; 2020; 2111():285-293. PubMed ID: 31933215
[TBL] [Abstract][Full Text] [Related]
14. T-cell activation by transitory neo-antigens derived from distinct microbial pathways.
Corbett AJ; Eckle SB; Birkinshaw RW; Liu L; Patel O; Mahony J; Chen Z; Reantragoon R; Meehan B; Cao H; Williamson NA; Strugnell RA; Van Sinderen D; Mak JY; Fairlie DP; Kjer-Nielsen L; Rossjohn J; McCluskey J
Nature; 2014 May; 509(7500):361-5. PubMed ID: 24695216
[TBL] [Abstract][Full Text] [Related]
15. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
[TBL] [Abstract][Full Text] [Related]
16. Human liver CD8
Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
[TBL] [Abstract][Full Text] [Related]
17. The effect of MR1 ligand glyco-analogues on mucosal-associated invariant T (MAIT) cell activation.
Braganza CD; Shibata K; Fujiwara A; Motozono C; Sonoda KH; Yamasaki S; Stocker BL; Timmer MSM
Org Biomol Chem; 2019 Oct; 17(40):8992-9000. PubMed ID: 31497838
[TBL] [Abstract][Full Text] [Related]
18. MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1.
Yan J; Allen S; McDonald E; Das I; Mak JYW; Liu L; Fairlie DP; Meehan BS; Chen Z; Corbett AJ; Varelias A; Smyth MJ; Teng MWL
Cancer Discov; 2020 Jan; 10(1):124-141. PubMed ID: 31826876
[TBL] [Abstract][Full Text] [Related]
19. MAIT cells and the microbiome.
Jabeen MF; Hinks TSC
Front Immunol; 2023; 14():1127588. PubMed ID: 36911683
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
